S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   16.98 (+0.30%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.65 (+1.12%)
DIS   111.95 (+0.33%)
AMC   4.36 (+0.93%)
PFE   26.59 (+0.11%)
PYPL   60.54 (+0.33%)
XOM   105.84 (+1.26%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   16.98 (+0.30%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.65 (+1.12%)
DIS   111.95 (+0.33%)
AMC   4.36 (+0.93%)
PFE   26.59 (+0.11%)
PYPL   60.54 (+0.33%)
XOM   105.84 (+1.26%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   16.98 (+0.30%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.65 (+1.12%)
DIS   111.95 (+0.33%)
AMC   4.36 (+0.93%)
PFE   26.59 (+0.11%)
PYPL   60.54 (+0.33%)
XOM   105.84 (+1.26%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   16.98 (+0.30%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.65 (+1.12%)
DIS   111.95 (+0.33%)
AMC   4.36 (+0.93%)
PFE   26.59 (+0.11%)
PYPL   60.54 (+0.33%)
XOM   105.84 (+1.26%)

Microsoft Fast Integrating AI Into Enterprise & Healthcare Suites

Microsoft Fast Integrating AI Into Enterprise & Healthcare Suites

Key Points

  • The company has been making headlines recently as it rolls out its Teams Premium service with features supported by the OpenAI’s GPT-3.5 AI language model.
  • In January, the company announced a multi-billion dollar investment in OpenAI.
  • It also forged a partnership with healthcare AI specialist Paige.
  • These moves follow its 2022 acquisition of speech-recognition AI company Nuance, also part of Microsoft's healthcare line of products. 
  • 5 stocks we like better than Microsoft

If you’re still thinking of Microsoft Corporation NASDAQ: MSFT as a sleepy maker of productivity tools, then its massive forays into the world of artificial intelligence may surprise you. 

More of its product offerings incorporate AI solutions as the company aims to grow its capabilities in search, enterprise and productivity, and healthcare, to name just a few areas. 

The company has been making headlines recently as it rolls out its Teams Premium service with features supported by OpenAI’s GPT-3.5 AI language model. The new features include an “intelligent recap” automatically generating tasks, notes, meeting highlights, and other functions. 

Microsoft is promoting the intelligent recap as the biggest benefit of the new rollout, as it’s hoping to attract customers to pay a $ 7-a-month introductory rate, which increases to $10 a month in June. 

Hasten Speed Of Commercialization 

In January, Microsoft closed on a multi-billion dollar investment in OpenAI, which developed the much-publicized ChatGPT. Microsoft has been nibbling at OpenAI, with previous investments in 2019 and 2021, with the hope of commercializing the technologies and speeding up the pace of research and development. 

Many analysts believe Microsoft will use the OpenAI partnership to breathe new life into its also-ran search engine Bing, with the hope of nabbing some market share from Alphabet Inc. NASDAQ: GOOGL

As huge as that would be for Microsoft’s search business, it plans to introduce AI technologies throughout its product lines. For example, in January, the company said it might add ChatGPT technology to its Microsoft 365 software suite, including widely used products Word, PowerPoint and Outlook. 

De Facto Corporate Standard

Although Apple Inc. NASDAQ: AAPL has made significant inroads among enterprise customers, Microsoft 365 products are still the de-facto standard in corporate settings. That means vast numbers of users would have exposure to the ChatGPT features, which may be used to create text with a single prompt and allow users to perform tasks faster and more accurately. 


Some analysts believe Microsoft is inching toward an outright acquisition of OpenAI.

Also in January, healthcare AI company Paige announced a partnership with Microsoft 

to develop and deliver clinical applications and biomarkers to advance cancer diagnoses and patient care. In its announcement, Paige said, “Microsoft will also make a strategic investment in Paige to accelerate the development and deployment of life-saving AI diagnostics.”

That may also hint at an eventual outright acquisition of the privately held Paige. 

Paige will use Microsoft Azure as the cloud provider for its Paige Platform, which powers a lab’s digital pathology workflow. Paige is becoming a  Microsoft Cloud for Healthcare partner, which expands Microsoft’s healthcare offerings.  

Rapidly Expanding Healthcare Capabilities

Microsoft has been expanding its capabilities in the healthcare field, with an emphasis on integrating AI applications.

 In March 2022, it completed the acquisition of Nuance, a speech-recognition software. In particular, Microsoft was focused on integrating Nuance into its  Microsoft Cloud for Healthcare suite, which was introduced in 2020.

Nuance’s healthcare-specific products include the Dragon Ambient eXperience, Dragon Medical One, and PowerScribe One. In its release announcing the Nuance acquisition, Microsoft said, “Nuance’s solutions work seamlessly with core healthcare systems, including longstanding relationships with Electronic Health Records (EHRs), to alleviate the burden of clinical documentation and empower providers to deliver better patient experiences.”

Microsoft’s chart shows the stock has been in rally mode this year, advancing 5.39% in 2023. Shares are still well below their November high of $349.67 but have notched upside gains in the past three weeks.

In January, the company got negative attention when it announced that it would lay off 10,000 employees. It also reported that revenue for its Azure cloud-computing unit was decelerating. However, the company is taking steps to expand its business in new directions that could make it an attractive investment candidate for those seeking more stable growth and a small dividend yield

Microsoft has increased its dividend in the past 20 years, landing it a spot on MarketBeat’s dividend achievers list.

→ This is the #1 Stock to Buy for the AI Tidal Wave (From Chaikin Analytics) (Ad)

Should you invest $1,000 in Microsoft right now?

Before you consider Microsoft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microsoft wasn't on the list.

While Microsoft currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Microsoft (MSFT)
4.8954 of 5 stars
$415.50+0.4%0.72%37.57Moderate Buy$411.06
Alphabet (GOOGL)
3.414 of 5 stars
$137.14-1.0%N/A23.64Moderate Buy$153.65
Apple (AAPL)
4.8845 of 5 stars
$179.66-0.6%0.53%27.98Moderate Buy$205.27
Compare These Stocks  Add These Stocks to My Watchlist 

Kate Stalter

About Kate Stalter

  • stalterkate@gmail.com

Contributing Author

Retirement, Asset Allocation, and Tax Strategies

Experience

Kate Stalter has been a contributing writer for MarketBeat since 2021.

Additional Experience

Series 65-licensed investment advisor, financial advisor, Blue Marlin Advisors; investment columnist for Forbes, U.S. News & World Report

Areas of Expertise

Asset allocation, technical and fundamental analysis, retirement strategies, income generation, risk management, sector and industry analysis

Education

Bachelor of Arts, Saint Mary’s College, Notre Dame, Indiana; Master of Business Adminstration, Kellogg School of Management at Northwestern University

Past Experience

Founder, financial advisor for Better Money Decisions; editor, stock trading instructor for Investor’s Business Daily; columnist, podcast host, video host for MoneyShow.com; contributor for Morningstar magazine


Featured Articles and Offers

Microsoft Stock to $450? Here's How

Microsoft Stock to $450? Here's How

Microsoft's stock price is pulling back following the Q4 results, suggesting a top is in play, but investors should not be so quick to shed their shares.

Search Headlines: